|3CC5: H-2db Complex With Human Gp100 |
reference: Design of agonistic altered peptides for the robust induction of CTL directed towards H-2Db in complex with the melanoma-associated epitope gp100., van Stipdonk MJ, Badia-Martinez D, Sluijter M, Offringa R, van Hall T, Achour A, Cancer Res. 2009 Oct 1;69(19):7784-92. Epub 2009 Sep 29. PMID: 19789338
uses Jmol, developed by the Jmol Development Team (documentation).